|generic name||brand name||drug class or drug category||general use|
|amphetamine/dextroamphetamine||Adderall||central nervous system stimulant||ADHD|
|dextroamphetamine||Dexedrine||central nervous system stimulant||attention-deficit hyperactivity disorder (ADHD)|
|fentanyl||Duragesic||narcotic analgesic||chronic pain|
|fentanyl citrate||Actiq; Fentora; Onsolis||narcotic (opioid) analgesic||to manage breakthrough pain in cancer patients|
|hydrocodone/acetaminophen||Lortab; Norco; Vicodin; Hycet||narcotic analgesic||to relieve moderate to severe pain|
|hydrocodone/chlorpheniramine||Tussicaps||narcotic cough suppressant and antihistamine||to treat symptoms due to cough, colds, allergies, or flu|
|hydrocodone/chlorpheniramine||Tussionex||narcotic antitussive and antihistamine||to treat symptoms due to cough, colds, allergies, or flu|
|hydrocodone, chlorpheniramine, pseudoephedrine||Zutripro||antitussive, antihistamine and nasal decongestant||for the relief of cough, nasal congestion, and upper respiratory allergies|
|hydrocodone/ibuprofen||Vicoprofen||narcotic (opioid) analgesic||short-term pain relief|
|hydrocodone/homatropine||Hycodan; Hydromet||anticholinergic and narcotic cough suppressant||indicated for the symptomatic relief of cough|
|hydromorphone||Dilaudid; Exalgo||narcotic analgesic; opioid agonist||to treat moderate to severe pain|
|lisdexamfetamine||Vyvanse||central nervous system stimulant||attention deficit hyperactivity disorder (ADHD)|
|meperidine||Demerol||narcotic analgesic||to treat moderate to severe pain|
|methadone||Dolophine; Methadose||narcotic analgesic; narcotic suppressant||to treat severe pain; to treat narcotic addiction|
|methylphenidate (oral)||Concerta; Ritalin; Methylin||central nervous system stimulant||ADHD|
|methylphenidate (patch)||Daytrana||central nervous system stimulant||ADHD|
|morphine sulfate||MS Contin; Kadian; Avinza; Oramorph||narcotic analgesic||moderate to severe pain|
|oxycodone||OxyContin; Roxicodone||narcotic analgesic||moderate to severe pain|
|oxycodone/acetaminophen||Percocet||narcotic analgesic||moderate to severe pain|
|oxymorphone||Opana||narcotic pain reliever||to treat moderate-to-severe pain|
|tapentadol||Nucynta||opioid analgesic||moderate to severe acute pain|
Schedule II same as C-II|
--- substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.
--- there are no refills for a C-II prescription.
--- federal law requires the patient's street address on Rx's for controlled substances.
--- prescriptions for Schedule II controlled substances must be written and be signed by the practitioner.
--- a C-II prescription must have the control number, physician's DEA number, and physician's DPS number.
--- in some states, a C-II prescription must be filled within 7 days of issue and in other states it must be filled within 72 hours. In Texas, a C-II prescription must be filled within 21 days of issue.
--- labels for C-II controlled substances must contain the fill date.
--- for C-II drugs, the auxiliary label "Transfer Warning" is required.
--- labels for C-II drugs should contain the statement, "Caution: Federal law prohibits the transfer of this drug to any person other than the person for whom it was prescribed."
--- after a pharmacist fills a C-II prescription, the pharmacist must sign and date the original prescription and this prescription must be filed separately from other prescriptions.
--- schedule II controlled substance prescriptions, written for a patient enrolled in hospice, may be faxed to a pharmacy for dispensing.
--- physician assistants (PA) and advanced practice nurses (APN) are not allowed to issue prescriptions for C-II drugs.
--- in emergency situations, a prescription for a Schedule II controlled substance may be telephoned to the pharmacy and the prescriber must follow up with a written prescription being sent to the pharmacy within 72 hours.
--- a DEA triplicate form 222 must be used when ordering C-II drugs. Purchase of C-II drugs must be authorized by a pharmacist on the DEA form.
--- a physical inventory of C-II drugs is required every two years.